SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001725160-23-000080
Filing Date
2023-04-28
Accepted
2023-04-28 16:39:11
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq Description Document Type Size
1 ARS pdfforars-workiva.pdf ARS 1766115
  Complete submission text file 0001725160-23-000080.txt   2433713
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39263 | Film No.: 23867314
SIC: 2834 Pharmaceutical Preparations